Viral subversion of the immune system.
暂无分享,去创建一个
H. Ploegh | D. Tortorella | D. Schust | H L Ploegh | M. Furman | D Tortorella | B E Gewurz | M H Furman | D J Schust | B. Gewurz | Margo H. Furman
[1] H. Thomas,et al. Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons alpha and gamma and double-stranded RNA. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[2] B. Cullen,et al. Human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus Nef use distinct but overlapping target sites for downregulation of cell surface CD4 , 1997, Journal of virology.
[3] H. Ploegh,et al. Human cytomegalovirus down-regulates HLA class I expression by reducing the stability of class I H chains. , 1993, Journal of immunology.
[4] J. Banchereau,et al. The EBV IL-10 homologue is a selective agonist with impaired binding to the IL-10 receptor. , 1997, Journal of immunology.
[5] M. Heise,et al. The T-cell-independent role of gamma interferon and tumor necrosis factor alpha in macrophage activation during murine cytomegalovirus and herpes simplex virus infections , 1995, Journal of virology.
[6] R. Moyer,et al. Activation of Caspases in Pig Kidney Cells Infected with Wild-Type and CrmA/SPI-2 Mutants of Cowpox and Rabbitpox Viruses , 1998, Journal of Virology.
[7] A. Cebrián,et al. Inhibition of apoptosis by the African swine fever virus Bcl-2 homologue: role of the BH1 domain. , 1997, Virology.
[8] M. Pandori,et al. The dileucine-based sorting motif in HIV-1 Nef is not required for down-regulation of class I MHC. , 1999, Virology.
[9] A. Berk,et al. Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein , 1992, Nature.
[10] R. Dubose,et al. The Epstein-Barr Virus BARF1 Gene Encodes a Novel, Soluble Colony-Stimulating Factor-1 Receptor , 1998, Journal of Virology.
[11] E. Kieff,et al. Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[12] E. White,et al. Btf, a Novel Death-Promoting Transcriptional Repressor That Interacts with Bcl-2-Related Proteins , 1999, Molecular and Cellular Biology.
[13] H. Browne,et al. Construction and characterization of a human cytomegalovirus mutant with the UL18 (class I homolog) gene deleted , 1992, Journal of virology.
[14] D. Black,et al. Sequence analysis of HindIII Q2 fragment of capripoxvirus reveals a putative gene encoding a G-protein-coupled chemokine receptor homologue. , 1995, Virology.
[15] M. Foti,et al. Mechanism of Nef‐induced CD4 endocytosis: Nef connects CD4 with the μ chain of adaptor complexes , 1998, The EMBO journal.
[16] T. Ranheim,et al. The adenovirus E3-14.7K protein and the E3-10.4K/14.5K complex of proteins, which independently inhibit tumor necrosis factor (TNF)-induced apoptosis, also independently inhibit TNF-induced release of arachidonic acid , 1996, Journal of virology.
[17] J. Grundy,et al. Human Cytomegalovirus Induces an Fe γ Receptor (FcγR) in Endothelial Cells and Fibroblasts that Is Distinct from the Human Cellular FcγRs , 1996 .
[18] R. Honess,et al. Herpesvirus saimiri encodes homologues of G protein-coupled receptors and cyclins , 1992, Nature.
[19] R. Schreiber,et al. Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3 , 1981, The Journal of experimental medicine.
[20] H. Prentice,et al. Natural killer cell lysis of cytomegalovirus (CMV)-infected cells correlates with virally induced changes in cell surface lymphocyte function-associated antigen-3 (LFA-3) expression and not with the CMV-induced down-regulation of cell surface class I HLA. , 1998, Journal of immunology.
[21] M. A. Jabbar,et al. Phosphorylation of both phosphoacceptor sites in the HIV-1 Vpu cytoplasmic domain is essential for Vpu-mediated ER degradation of CD4. , 1997, Virology.
[22] Stephen J. Elledge,et al. SKP1 Connects Cell Cycle Regulators to the Ubiquitin Proteolysis Machinery through a Novel Motif, the F-Box , 1996, Cell.
[23] D. Rock,et al. A BIR motif containing gene of African swine fever virus, 4CL, is nonessential for growth in vitro and viral virulence. , 1997, Virology.
[24] G. McFadden,et al. Virus-encoded receptors for cytokines and chemokines. , 1998, Seminars in cell & developmental biology.
[25] E. Cheng,et al. Herpesvirus saimiri encodes a functional homolog of the human bcl-2 oncogene , 1997, Journal of virology.
[26] Jean Gruenberg,et al. Nef-Induced CD4 Degradation A Diacidic-Based Motif in Nef Functions as a Lysosomal Targeting Signal through the Binding of β-COP in Endosomes , 1999, Cell.
[27] K. Rock. A new foreign policy: MHC class I molecules monitor the outside world. , 1996, Immunology today.
[28] A. Alcamí,et al. Vaccinia virus serpin B13R (SPI-2) inhibits interleukin-1beta-converting enzyme and protects virus-infected cells from TNF- and Fas-mediated apoptosis, but does not prevent IL-1beta-induced fever. , 1997, The Journal of general virology.
[29] E Tom,et al. Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains , 1996, Journal of virology.
[30] J. Mcdougal,et al. Binding of the human retrovirus HTLV-III/LAV/ARV/HIV to the CD4 (T4) molecule: conformation dependence, epitope mapping, antibody inhibition, and potential for idiotypic mimicry. , 1986, Journal of immunology.
[31] M. Bogyo,et al. The Human Cytomegalovirus US11 Gene Product Dislocates MHC Class I Heavy Chains from the Endoplasmic Reticulum to the Cytosol , 1996, Cell.
[32] Ashley T. Haase,et al. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS , 1993, Nature.
[33] R. Benarous,et al. Interaction between the cytoplasmic domains of HIV-1 Vpu and CD4: role of Vpu residues involved in CD4 interaction and in vitro CD4 degradation. , 1996, Virology.
[34] P. Cresswell,et al. Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4+ T cells , 1999, Nature Medicine.
[35] C. Boshoff,et al. Molecular Mimicry of Human Cytokine and Cytokine Response Pathway Genes by KSHV , 1996, Science.
[36] T. Rapoport,et al. The Pathway of Us11-Dependent Degradation of Mhc Class I Heavy Chains Involves a Ubiquitin-Conjugated Intermediate , 1999, The Journal of cell biology.
[37] William Arbuthnot Sir Lane,et al. The MHC class I homolog encoded by human cytomegalovirus binds endogenous peptides. , 1995, Immunity.
[38] T. Shenk,et al. Protection against apoptosis by the vaccinia virus SPI-2 (B13R) gene product , 1996, Journal of virology.
[39] G. Sen,et al. Restoration of interferon responses of adenovirus E1A-expressing HT1080 cell lines by overexpression of p48 protein , 1997, Journal of virology.
[40] L. Payne. Significance of extracellular enveloped virus in the in vitro and in vivo dissemination of vaccinia. , 1980, The Journal of general virology.
[41] Tyson V. Sharp,et al. Activation of the interferon-inducible (2'-5') oligoadenylate synthetase by the Epstein-Barr virus RNA, EBER-1. , 1999, Virology.
[42] B. Fleckenstein,et al. Inhibition of complement-mediated cytolysis by the terminal complement inhibitor of herpesvirus saimiri , 1994, Journal of virology.
[43] D. Wallach,et al. Soluble cytokine receptors are present in normal human urine , 1989, The Journal of experimental medicine.
[44] H. Vally,et al. Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo , 1997, Nature.
[45] S. Pierce,et al. Regulation of B cell receptor-mediated MHC class II antigen processing by FcgammaRIIB1. , 1999, Journal of immunology.
[46] G. Smith. Virus proteins that bind cytokines, chemokines or interferons. , 1996, Current opinion in immunology.
[47] J. Russo,et al. Kaposi's sarcoma-associated herpesvirus encodes a functional Bcl-2 homologue , 1997, Nature Medicine.
[48] G. McFadden,et al. Immunomodulation by viruses: the myxoma virus story , 1999, Immunological reviews.
[49] L. Lanier,et al. Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. , 1996, Journal of immunology.
[50] A. Alcamí,et al. Blockade of chemokine activity by a soluble chemokine binding protein from vaccinia virus. , 1998, Journal of immunology.
[51] J. Hiscott,et al. Primary activation of interferon A and interferon B gene transcription by interferon regulatory factor 3. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[52] E. Jaffe,et al. Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. , 1999, Blood.
[53] T. Farrah,et al. The extracellular domain of the Epstein-Barr virus BZLF2 protein binds the HLA-DR beta chain and inhibits antigen presentation , 1996, Journal of virology.
[54] T. Klimkait,et al. A novel gene of HIV-1, vpu, and its 16-kilodalton product. , 1988, Science.
[55] H. Chapman,et al. Endosomal proteolysis and MHC class II function. , 1998, Current opinion in immunology.
[56] J. Yewdell,et al. CD4 Glycoprotein Degradation Induced by Human Immunodeficiency Virus Type 1 Vpu Protein Requires the Function of Proteasomes and the Ubiquitin-Conjugating Pathway , 1998, Journal of Virology.
[57] H. Ploegh,et al. Generation, translocation, and presentation of MHC class I-restricted peptides. , 1995, Annual review of biochemistry.
[58] M. Degli-Esposti,et al. The Murine Cytomegalovirus Chemokine Homolog, m131/129, Is a Determinant of Viral Pathogenicity , 1999, Journal of Virology.
[59] E. Meinl,et al. Anti-apoptotic strategies of lymphotropic viruses. , 1998, Immunology today.
[60] M. Katze,et al. Inhibition of Double-Stranded RNA-Dependent Protein Kinase PKR by Vaccinia Virus E3: Role of Complex Formation and the E3 N-Terminal Domain , 1998, Molecular and Cellular Biology.
[61] R. Moyer,et al. DNA sequence analysis of conserved and unique regions of swinepox virus: identification of genetic elements supporting phenotypic observations including a novel G protein-coupled receptor homologue. , 1993, Virology.
[62] H. Thomas,et al. Expression of the terminal protein of hepatitis B virus is associated with failure to respond to interferon therapy , 1993, Hepatology.
[63] E. Telford,et al. The DNA sequence of equine herpesvirus 2. , 1995, Journal of molecular biology.
[64] M. Su,et al. Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells. , 1998, The Journal of clinical investigation.
[65] H. Ploegh,et al. Dislocation of Type I Membrane Proteins from the ER to the Cytosol Is Sensitive to Changes in Redox Potential , 1998, The Journal of cell biology.
[66] E. Cesarman,et al. Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma , 1996, Journal of virology.
[67] M. Dierich,et al. Efficient destruction of human immunodeficiency virus in human serum by inhibiting the protective action of complement factor H and decay accelerating factor (DAF, CD55) , 1996, The Journal of experimental medicine.
[68] A. Gruhler,et al. A comparison of viral immune escape strategies targeting the MHC class I assembly pathway , 1999, Immunological reviews.
[69] E. Kieff,et al. Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development , 1992, The Journal of experimental medicine.
[70] E. Kieff. Epstein-Barr virus and its replication , 1996 .
[71] H. Ploegh,et al. The WD‐40 repeat , 1992, FEBS letters.
[72] G. Nemerow,et al. Epstein-Barr virus regulates activation and processing of the third component of complement , 1988, The Journal of experimental medicine.
[73] D. Baltimore,et al. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. , 1999, Immunity.
[74] J. Yewdell,et al. Herpes simplex virus turns off the TAP to evade host immunity , 1995, Nature.
[75] T. Nagashunmugam,et al. Viral interference with antibody and complement , 1998, Seminars in Cell & Developmental Biology.
[76] F. Neipel,et al. Cell-homologous genes in the Kaposi's sarcoma-associated rhadinovirus human herpesvirus 8: determinants of its pathogenicity? , 1997, Journal of virology.
[77] R. Eversole,et al. Multiple anti-cytokine activities secreted from tanapox virus-infected cells. , 1994, Microbial pathogenesis.
[78] D. Thomas,et al. A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. , 1998, Molecular cell.
[79] R. Schlegel,et al. Vacuolar H+-ATPase Mutants Transform Cells and Define a Binding Site for the Papillomavirus E5 Oncoprotein (*) , 1995, The Journal of Biological Chemistry.
[80] R. F. Cook,et al. The Active Site of ICP47, a Herpes Simplex Virus–encoded Inhibitor of the Major Histocompatibility Complex (MHC)-encoded Peptide Transporter Associated with Antigen Processing (TAP), Maps to the NH2-terminal 35 Residues , 1997, The Journal of experimental medicine.
[81] B. Roizman,et al. The γ134.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1α to dephosphorylate the α subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase , 1997 .
[82] C. Smith,et al. Cowpox virus contains two copies of an early gene encoding a soluble secreted form of the type II TNF receptor. , 1994, Virology.
[83] G. Chinnadurai,et al. Epstein-Barr virus BHRF1 protein protects against cell death induced by DNA-damaging agents and heterologous viral infection. , 1994, Virology.
[84] P. Oostveldt,et al. Antibody-induced and cytoskeleton-mediated redistribution and shedding of viral glycoproteins, expressed on pseudorabies virus-infected cells , 1997, Journal of virology.
[85] L. W. Parks,et al. The activity of cytosolic phospholipase A2 is required for the lysis of adenovirus-infected cells by tumor necrosis factor , 1996, Journal of virology.
[86] J. Tschopp,et al. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors , 1997, Nature.
[87] W. Jefferies,et al. E3/19K from adenovirus 2 is an immunosubversive protein that binds to a structural motif regulating the intracellular transport of major histocompatibility complex class I proteins , 1990, The Journal of experimental medicine.
[88] G. Sen,et al. Effects of adenovirus E1A protein on interferon-signaling. , 1996, Virology.
[89] P. Cresswell,et al. The thiol oxidoreductase ERp57 is a component of the MHC class I peptide-loading complex , 1998, Current Biology.
[90] R. Means,et al. A role for carbohydrates in immune evasion in AIDS , 1998, Nature Medicine.
[91] E. Cheng,et al. A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[92] R. Eisenberg,et al. Mechanism of complement inactivation by glycoprotein C of herpes simplex virus. , 1997, Journal of immunology.
[93] G. Johnson,et al. Intracellular Signaling by the Chemokine Receptor US28 during Human Cytomegalovirus Infection , 1998, Journal of Virology.
[94] J. Ruby,et al. Evasion of apoptosis by DNA viruses , 1996, Immunology and cell biology.
[95] T. Ley,et al. How do cytotoxic lymphocytes kill their targets? , 1998, Current opinion in immunology.
[96] Antonio Alcami,et al. A soluble receptor for interleukin-1β encoded by vaccinia virus: A novel mechanism of virus modulation of the host response to infection , 1992, Cell.
[97] H. Virgin,et al. Spliced mRNA Encoding the Murine Cytomegalovirus Chemokine Homolog Predicts a β Chemokine of Novel Structure , 1999, Journal of Virology.
[98] A. Ensser,et al. Primary structure of the alcelaphine herpesvirus 1 genome , 1997, Journal of virology.
[99] B. Moss,et al. Regulation of complement activity by vaccinia virus complement-control protein. , 1992, The Journal of infectious diseases.
[100] B. Barrell,et al. Human cytomegalovirus encodes three G protein-coupled receptor homologues , 1990, Nature.
[101] C. Van Sant,et al. The herpes simplex virus 1 protein kinase US3 is required for protection from apoptosis induced by the virus. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[102] L. Lopalco,et al. HIV glycoprotein 41 and complement factor H interact with each other and share functional as well as antigenic homology. , 1995, AIDS research and human retroviruses.
[103] S. Grzesiek,et al. The solution structure of HIV-1 Nef reveals an unexpected fold and permits delineation of the binding surface for the SH3 domain of Hck tyrosine protein kinase , 1996, Nature Structural Biology.
[104] J. Neefjes,et al. Interleukin-10 Down-Regulates MHC Class II αβ Peptide Complexes at the Plasma Membrane of Monocytes by Affecting Arrival and Recycling , 1997 .
[105] J. Oldridge,et al. Nef--an adaptor adaptor? , 1998, Trends in cell biology.
[106] V. Dixit,et al. Death receptors: signaling and modulation. , 1998, Science.
[107] S. Heath,et al. Follicular dendritic cells (FDC) in retroviral infection: host/pathogen perspectives , 1997, Immunological reviews.
[108] B. Barrell,et al. Primary structure and transcription of the genes coding for the two virion phosphoproteins pp65 and pp71 of human cytomegalovirus , 1987, Journal of virology.
[109] H. Ljunggren,et al. In search of the 'missing self': MHC molecules and NK cell recognition. , 1990, Immunology today.
[110] M. Kubin,et al. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. , 1997, Immunity.
[111] J. Atkinson,et al. Herpes simplex virus glycoproteins gC-1 and gC-2 bind to the third component of complement and provide protection against complement- mediated neutralization of viral infectivity , 1987, The Journal of experimental medicine.
[112] G. McFadden,et al. Role of the myxoma virus soluble CC-chemokine inhibitor glycoprotein, M-T1, during myxoma virus pathogenesis. , 1999, Virology.
[113] P. Howley,et al. The transcriptional transactivation function of wild‐type p53 is inhibited by SV40 large T‐antigen and by HPV‐16 E6 oncoprotein. , 1992, The EMBO journal.
[114] C. Ware,et al. The adenovirus E3-10.4K/14.5K complex mediates loss of cell surface Fas (CD95) and resistance to Fas-induced apoptosis , 1997, Journal of virology.
[115] J. Ravetch. Fc receptors: Rubor redux , 1994, Cell.
[116] P. Cresswell,et al. The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[117] J. Sodroski,et al. Decay‐accelerating factor (CD55) protects human immunodeficiency virus type 1 from inactivation by human complement , 1995, European journal of immunology.
[118] B. McManus,et al. Complement component 3 interactions with coxsackievirus B3 capsid proteins: innate immunity and the rapid formation of splenic antiviral germinal centers , 1997, Journal of virology.
[119] H. Friedman,et al. Herpes simplex virus type 1 Fc receptor protects infected cells from antibody-dependent cellular cytotoxicity , 1991, Journal of virology.
[120] J. Yewdell,et al. The Human Immunodeficiency Virus Type 1 (HIV-1) Vpu Protein Interferes with an Early Step in the Biosynthesis of Major Histocompatibility Complex (MHC) Class I Molecules , 1997, The Journal of experimental medicine.
[121] G. Sutter,et al. Serp2, an Inhibitor of the Interleukin-1β-Converting Enzyme, Is Critical in the Pathobiology of Myxoma Virus , 1998, Journal of Virology.
[122] R. Plemper,et al. Retrograde protein translocation: ERADication of secretory proteins in health and disease. , 1999, Trends in biochemical sciences.
[123] G. McFadden,et al. The Myxoma Virus-soluble Interferon- Receptor Homolog, M-T7, Inhibits Interferon- in a Species-specific Manner (*) , 1995, The Journal of Biological Chemistry.
[124] K. Kitajima,et al. Purification and enzymatic properties of peptide:N-glycanase from C3H mouse-derived L-929 fibroblast cells. Possible widespread occurrence of post-translational remodification of proteins by N-deglycosylation. , 1994, The Journal of biological chemistry.
[125] P. Spear,et al. Similarities and differences in the Fc-binding glycoprotein (gE) of herpes simplex virus types 1 and 2 and tentative mapping of the viral gene for this glycoprotein , 1982, Journal of virology.
[126] A. Hasegawa,et al. Down-regulation of CXCR4 by human herpesvirus 6 (HHV-6) and HHV-7. , 1999, Journal of immunology.
[127] S. Morrison,et al. Characterization of the Interaction between the Herpes Simplex Virus Type I Fc Receptor and Immunoglobulin G* , 1999, The Journal of Biological Chemistry.
[128] J C Reed,et al. IAP family proteins--suppressors of apoptosis. , 1999, Genes & development.
[129] E. Kieff,et al. BHRF1, the Epstein-Barr virus gene with homology to Bc12, is dispensable for B-lymphocyte transformation and virus replication , 1991, Journal of virology.
[130] L. Moretta,et al. The leukocyte Ig-like receptor (LIR)-1 for the cytomegalovirus UL18 protein displays a broad specificity for different HLA class I alleles: analysis of LIR-1 + NK cell clones. , 1999, International immunology.
[131] P. Openshaw,et al. Intracellular IFN-gamma expression in natural killer cells precedes lung CD8+ T cell recruitment during respiratory syncytial virus infection. , 1998, The Journal of general virology.
[132] A. Mantovani,et al. Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells. , 1998, Journal of immunology.
[133] R. Welsh,et al. Adoptive transfer studies demonstrating the antiviral effect of natural killer cells in vivo , 1985, The Journal of experimental medicine.
[134] D. Lowy,et al. The bovine papillomavirus E5 transforming protein can stimulate the transforming activity of EGF and CSF-1 receptors , 1989, Cell.
[135] B. Woda,et al. Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo. , 1983, Journal of immunology.
[136] Y. Li,et al. Interaction of an adenovirus 14.7-kilodalton protein inhibitor of tumor necrosis factor alpha cytolysis with a new member of the GTPase superfamily of signal transducers , 1997, Journal of virology.
[137] P. Pitha,et al. Unique properties of a second human herpesvirus 8-encoded interferon regulatory factor (vIRF-2). , 1999, Journal of human virology.
[138] R. Burton,et al. The effect of the Cmv-1 resistance gene, which is linked to the natural killer cell gene complex, is mediated by natural killer cells. , 1992, Journal of immunology.
[139] G. McFadden,et al. Apoptosis regulators from DNA viruses. , 1998, Current opinion in immunology.
[140] P. Cresswell,et al. Association of human class I MHC alleles with the adenovirus E3/19K protein. , 1994, Journal of immunology.
[141] H. Virgin,et al. Murine Gammaherpesvirus 68 Encodes a Functional Regulator of Complement Activation , 1999, Journal of Virology.
[142] Mike Rothe,et al. The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins , 1995, Cell.
[143] J. Yewdell,et al. Retention of adenovirus E19 glycoprotein in the endoplasmic reticulum is essential to its ability to block antigen presentation , 1991, The Journal of experimental medicine.
[144] M. Daëron,et al. Fc receptor biology. , 2003, Annual review of immunology.
[145] Stefan Imreh,et al. A minimal glycine-alanine repeat prevents the interaction of ubiquitinated IκBα with the proteasome: a new mechanism for selective inhibition of proteolysis , 1998, Nature Medicine.
[146] L. Yu,et al. The role of LY49 NK cell subsets in the regulation of murine cytomegalovirus infections. , 1999, Journal of immunology.
[147] D. Trono,et al. The downregulation of CD4 and MHC‐I by primate lentiviruses: a paradigm for the modulation of cell surface receptors , 1999, Immunological reviews.
[148] A Ciechanover,et al. Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[149] S. Le Gall,et al. Nef interacts with the mu subunit of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC I molecules. , 1998, Immunity.
[150] M. Jackson,et al. Identification of a consensus motif for retention of transmembrane proteins in the endoplasmic reticulum. , 1990, The EMBO journal.
[151] M. Scheffner,et al. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53 , 1993, Cell.
[152] C. Smith,et al. Cowpox virus genome encodes a second soluble homologue of cellular TNF receptors, distinct from CrmB, that binds TNF but not LT alpha. , 1996, Virology.
[153] Y. Tanaka,et al. Differential effect of adenovirus 2 E3/19K glycoprotein on the expression of H-2Kb and H-2Db class I antigens and H-2Kb- and H-2Db-restricted SV40-specific CTL-mediated lysis. , 1988, Virology.
[154] B. Woda,et al. Pathogenesis of murine cytomegalovirus infection in natural killer cell-depleted mice , 1984, Journal of virology.
[155] A. Sette,et al. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells , 1994, Nature.
[156] S. Grzesiek,et al. The CD4 determinant for downregulation by HIV-1 Nef directly binds to Nef. Mapping of the Nef binding surface by NMR. , 1996, Biochemistry.
[157] J. Skowroński,et al. Separable functions of Nef disrupt two aspects of T cell receptor machinery: CD4 expression and CD3 signaling , 1997, The EMBO journal.
[158] Wei Wu,et al. Identification and functional characterization of a second chain of the interleukin‐10 receptor complex , 1997, The EMBO journal.
[159] G. Bancroft,et al. Increased susceptibility to cytomegalovirus infection in beige mutant mice. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[160] W. Jackson,et al. Receptor properties of two varicella-zoster virus glycoproteins, gpI and gpIV, homologous to herpes simplex virus gE and gI , 1992, Journal of virology.
[161] P. A. Peterson,et al. Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus ICP47. , 1996, The EMBO journal.
[162] K. Siminovitch,et al. Recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by Fc gamma RIIB1. , 1995, Science.
[163] Geoffrey L. Smith,et al. Two vaccinia virus proteins structurally related to the interleukin-1 receptor and the immunoglobulin superfamily. , 1991, The Journal of general virology.
[164] S. Jonjić,et al. Site-restricted persistent cytomegalovirus infection after selective long-term depletion of CD4+ T lymphocytes , 1989, The Journal of experimental medicine.
[165] J. Yewdell,et al. Cutting edge: adenovirus E19 has two mechanisms for affecting class I MHC expression. , 1999, Journal of immunology.
[166] H. Ploegh,et al. Herpes simplex virus blocks intracellular transport of HLA-G in placentally derived human cells. , 1996, Journal of immunology.
[167] P. Branton,et al. Adenovirus E1B 19-kDa Death Suppressor Protein Interacts with Bax but Not with Bad* , 1996, The Journal of Biological Chemistry.
[168] P. Bjorkman,et al. Investigation of the interaction between the class I MHC-related Fc receptor and its immunoglobulin G ligand. , 1994, Immunity.
[169] Geoffrey L. Smith,et al. The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence. , 1993, Virology.
[170] Y. Hannun,et al. Cytokine response modifier A (CrmA): a strategically deployed viral weapon. , 1998, Clinical immunology and immunopathology.
[171] P. A. Peterson,et al. The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. , 1997, Immunity.
[172] J. Lubinski,et al. In Vivo Immune Evasion Mediated by the Herpes Simplex Virus Type 1 Immunoglobulin G Fc Receptor , 1998, Journal of Virology.
[173] D. McCance,et al. The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes , 1993, Journal of virology.
[174] R. Buller,et al. Vaccinia and cowpox viruses encode a novel secreted interleukin-1-binding protein , 1992, Cell.
[175] S. Riddell,et al. Selective interference with class I major histocompatibility complex presentation of the major immediate-early protein following infection with human cytomegalovirus , 1993, Journal of virology.
[176] M. Berry,et al. Ultraviolet-induced cell death blocked by a selenoprotein from a human dermatotropic poxvirus. , 1998, Science.
[177] B. Walker,et al. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes , 1998, Nature.
[178] G. McFadden,et al. The myxoma virus M-T4 gene encodes a novel RDEL-containing protein that is retained within the endoplasmic reticulum and is important for the productive infection of lymphocytes. , 1997, Virology.
[179] A. Enk,et al. IL-12 as mediator and adjuvant for the induction of contact sensitivity in vivo. , 1995, Journal of immunology.
[180] M. Rowe,et al. Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[181] G. McFadden,et al. The purified myxoma virus gamma interferon receptor homolog M-T7 interacts with the heparin-binding domains of chemokines , 1997, Journal of virology.
[182] B. Fleckenstein,et al. The two major structural phosphoproteins (pp65 and pp150) of human cytomegalovirus and their antigenic properties. , 1987, The Journal of general virology.
[183] Rinaldo Cr. Modulation of major histocompatibility complex antigen expression by viral infection. , 1994 .
[184] S. Riddell,et al. Cytomegalovirus selectively blocks antigen processing and presentation of its immediate–early gene product , 1996, Nature.
[185] É. Cohen,et al. Putative alpha-helical structures in the human immunodeficiency virus type 1 Vpu protein and CD4 are involved in binding and degradation of the CD4 molecule , 1997, Journal of virology.
[186] H. Ploegh,et al. How MHC class II molecules acquire peptide cargo: biosynthesis and trafficking through the endocytic pathway. , 1995, Annual review of cell and developmental biology.
[187] T. Shenk,et al. Human cytomegalovirus IE1 and IE2 proteins block apoptosis. , 1995, Journal of virology.
[188] G. McFadden,et al. Distinct domains of M-T2, the myxoma virus tumor necrosis factor (TNF) receptor homolog, mediate extracellular TNF binding and intracellular apoptosis inhibition , 1997, Journal of virology.
[189] M. Carroll,et al. The role of complement and complement receptors in induction and regulation of immunity. , 1998, Annual review of immunology.
[190] D. Schomburg,et al. Solution structure of the hydrophilic region of HIV-1 encoded virus protein U (Vpu) by CD and 1H NMR spectroscopy. , 2009, International journal of peptide and protein research.
[191] C. Speth,et al. Modulation of cell surface protein expression by infection with HIV-1 , 1999, Leukemia.
[192] Jian Kang,et al. Interaction of an Adenovirus E3 14.7-Kilodalton Protein with a Novel Tumor Necrosis Factor Alpha-Inducible Cellular Protein Containing Leucine Zipper Domains , 1998, Molecular and Cellular Biology.
[193] J. Bertin,et al. Bovine herpesvirus 4 BORFE2 protein inhibits Fas- and tumor necrosis factor receptor 1-induced apoptosis and contains death effector domains shared with other gamma-2 herpesviruses , 1997, Journal of virology.
[194] Wen-Hwa Lee,et al. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene , 1988, Cell.
[195] J. Hiscott,et al. Triggering the interferon response: the role of IRF-3 transcription factor. , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[196] S. K. Saha,et al. The 10,400- and 14,500-dalton proteins encoded by region E3 of adenovirus form a complex and function together to down-regulate the epidermal growth factor receptor , 1991, Journal of virology.
[197] Geoffrey L. Smith,et al. Vaccinia virus immune evasion. , 1999, Immunology letters.
[198] Sarah Rowland-Jones,et al. Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants , 1994, Nature.
[199] G. Fantuzzi,et al. Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. , 1999, Immunity.
[200] M. Heise,et al. Murine Cytomegalovirus Inhibits Interferon γ–induced Antigen Presentation to CD4 T Cells by Macrophages Via Regulation of Expression of Major Histocompatibility Complex Class II–associated Genes , 1998, The Journal of experimental medicine.
[201] K. Jeang,et al. Oncogenic potential of TAR RNA binding protein TRBP and its regulatory interaction with RNA‐dependent protein kinase PKR , 1997, The EMBO journal.
[202] S. Nagata,et al. Apoptosis by Death Factor , 1997, Cell.
[203] G. McFadden,et al. Myxoma virus expresses a secreted protein with homology to the tumor necrosis factor receptor gene family that contributes to viral virulence. , 1991, Virology.
[204] A. Elsing,et al. The adenovirus E3/10.4K-14.5K proteins down-modulate the apoptosis receptor Fas/Apo-1 by inducing its internalization. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[205] F. Bloom,et al. Interference with major histocompatibility complex class II-restricted antigen presentation in the brain by herpes simplex virus type 1: a possible mechanism of evasion of the immune response. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[206] B. Fleckenstein,et al. The complement control protein homolog of herpesvirus saimiri regulates serum complement by inhibiting C3 convertase activity , 1995, Journal of virology.
[207] M. Endres,et al. The Kaposi's Sarcoma–related Herpesvirus (KSHV)-encoded Chemokine vMIP-I is a Specific Agonist for the CC Chemokine Receptor (CCR)8 , 1999, The Journal of experimental medicine.
[208] Yen-Liang Chen,et al. Nef-Induced CD4 and Major Histocompatibility Complex Class I (MHC-I) Down-Regulation Are Governed by Distinct Determinants: N-Terminal Alpha Helix and Proline Repeat of Nef Selectively Regulate MHC-I Trafficking , 1999, Journal of Virology.
[209] E. Kieff,et al. Induction of bcl-2 expression by epstein-barr virus latent membrane protein 1 protects infected B cells from programmed cell death , 1991, Cell.
[210] G. F. Burton,et al. Follicular dendritic cells and human immunodeficiency virus infectivity , 1995, Nature.
[211] E. Paoletti,et al. TAR RNA-binding protein is an inhibitor of the interferon-induced protein kinase PKR. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[212] P. Latreille,et al. Complete sequence and genomic analysis of murine gammaherpesvirus 68 , 1997, Journal of virology.
[213] M. Greenberg,et al. A dileucine motif in HIV-1 Nef is essential for sorting into clathrin-coated pits and for downregulation of CD4 , 1998, Current Biology.
[214] F. Khanim,et al. BHRF1, a viral homologue of the Bcl-2 oncogene, is conserved at both the sequence and functional level in different Epstein-Barr virus isolates. , 1997, The Journal of general virology.
[215] B. Barrell,et al. Identification and characterization of a G protein-coupled receptor homolog encoded by murine cytomegalovirus , 1997, Journal of virology.
[216] T. Hanke,et al. Cloning of a mouse homolog of CD94 extends the family of C‐type lectins on murine natural killer cells , 1997, European journal of immunology.
[217] F. Brodsky,et al. Human pathogen subversion of antigen presentation , 1999, Immunological reviews.
[218] M. Smyth,et al. M144, a Murine Cytomegalovirus (Mcmv)-Encoded Major Histocompatibility Complex Class I Homologue, Confers Tumor Resistance to Natural Killer Cell–Mediated Rejection , 1999, The Journal of experimental medicine.
[219] L. Shultz,et al. Antiviral activity of NK 1.1+ natural killer cells in C57BL/6 scid mice infected with murine cytomegalovirus. , 1994, Natural immunity.
[220] T. Schall,et al. Chemokines, leukocyte trafficking, and inflammation. , 1994, Current opinion in immunology.
[221] T. Graf,et al. Epstein-Barr Virus Encodes a Novel Homolog of the bcl-2 Oncogene That Inhibits Apoptosis and Associates with Bax and Bak , 1999, Journal of Virology.
[222] F. Chisari,et al. To kill or to cure: options in host defense against viral infection. , 1996, Current opinion in immunology.
[223] P. Simmonds,et al. HIV-1 tropism and co-receptor use , 1997, Nature.
[224] D. Devine,et al. Altered expression of host‐encoded complement regulators on human cytomegalovirus‐infected cells , 1996, European journal of immunology.
[225] C. Figdor,et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression , 1991, The Journal of experimental medicine.
[226] P. Secchiero,et al. Human herpesvirus 7 induces the down-regulation of CD4 antigen in lymphoid T cells without affecting p56lck levels. , 1997, Journal of immunology.
[227] M. Baggiolini. Chemokines and leukocyte traffic , 1998, Nature.
[228] W. Wold,et al. Epidermal growth factor receptor is down-regulated by a 10,400 MW protein encoded by the E3 region of adenovirus , 1989, Cell.
[229] D. Wallach,et al. Identification of a cell protein (FIP-3) as a modulator of NF-κB activity and as a target of an adenovirus inhibitor of tumor necrosis factor α-induced apoptosis , 1999 .
[230] H. Friedman,et al. A novel function of the herpes simplex virus type 1 Fc receptor: participation in bipolar bridging of antiviral immunoglobulin G , 1989, Journal of virology.
[231] W. Wold,et al. Immune responses to adenoviruses: viral evasion mechanisms and their implications for the clinic. , 1999, Current opinion in immunology.
[232] M. K. Spriggs. Virus-encoded modulators of cytokines and growth factors. , 1999, Cytokine & growth factor reviews.
[233] R. Tampé,et al. A critical role for tapasin in the assembly and function of multimeric MHC class I-TAP complexes. , 1997, Science.
[234] C. Bruggeman,et al. The R33 G Protein-Coupled Receptor Gene of Rat Cytomegalovirus Plays an Essential Role in the Pathogenesis of Viral Infection , 1998, Journal of Virology.
[235] F. Takei,et al. Inhibition of NK cells by murine CMV-encoded class I MHC homologue m144. , 1998, Cellular immunology.
[236] Christopher C. Goodnow,et al. C3d of Complement as a Molecular Adjuvant: Bridging Innate and Acquired Immunity , 1996, Science.
[237] V. Koistinen,et al. Herpes simplex virus glycoprotein C: molecular mimicry of complement regulatory proteins by a viral protein. , 1993, Immunology.
[238] B Dewald,et al. Human chemokines: an update. , 1997, Annual review of immunology.
[239] G. McFadden,et al. The T1/35kDa family of poxvirus-secreted proteins bind chemokines and modulate leukocyte influx into virus-infected tissues. , 1997, Virology.
[240] G. McFadden,et al. Species Specificity of Ectromelia Virus and Vaccinia Virus Interferon-γ Binding Proteins , 1995 .
[241] B. Fleckenstein,et al. Herpesvirus saimiri has a gene specifying a homologue of the cellular membrane glycoprotein CD59. , 1992, Virology.
[242] M. Gerhart,et al. Poxvirus genomes encode a secreted, soluble protein that preferentially inhibits beta chemokine activity yet lacks sequence homology to known chemokine receptors. , 1997, Virology.
[243] P. A. Peterson,et al. A short sequence in the COOH-terminus makes an adenovirus membrane glycoprotein a resident of the endoplasmic reticulum , 1987, Cell.
[244] H. Ploegh,et al. Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[245] S. Benichou,et al. Physical interaction of the HIV-1 Nef protein with beta-COP, a component of non-clathrin-coated vesicles essential for membrane traffic. , 1994, The Journal of biological chemistry.
[246] U. Koszinowski,et al. A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments. , 1997, Immunity.
[247] P. Åman,et al. An Epstein‐Barr virus immortalization associated gene segment interferes specifically with the IFN‐induced anti‐proliferative response in human B‐lymphoid cell lines. , 1990, The EMBO journal.
[248] I. Kerr,et al. Activation of the ppp(A2'p)nA system in interferon-treated, herpes simplex virus-infected cells and evidence for novel inhibitors of the ppp(A2'p)nA-dependent RNase. , 1984, European journal of biochemistry.
[249] J. Hiscott,et al. Virus-Dependent Phosphorylation of the IRF-3 Transcription Factor Regulates Nuclear Translocation, Transactivation Potential, and Proteasome-Mediated Degradation , 1998, Molecular and Cellular Biology.
[250] U. Koszinowski,et al. Human cytomegalovirus inhibits peptide translocation into the endoplasmic reticulum for MHC class I assembly. , 1996, The Journal of general virology.
[251] T. Jackson. Transport vesicles: Coats of many colours , 1998, Current Biology.
[252] D. Sedmak,et al. Human Cytomegalovirus Inhibits IFN-α-Stimulated Antiviral and Immunoregulatory Responses by Blocking Multiple Levels of IFN-α Signal Transduction , 1999, The Journal of Immunology.
[253] T. Kirchhausen,et al. Interaction of the Bovine Papillomavirus E6 Protein with the Clathrin Adaptor Complex AP-1 , 1998, Journal of Virology.
[254] N. Lurain,et al. Host cell-derived complement control proteins CD55 and CD59 are incorporated into the virions of two unrelated enveloped viruses. Human T cell leukemia/lymphoma virus type I (HTLV-I) and human cytomegalovirus (HCMV). , 1995, Journal of immunology.
[255] N. Heveker,et al. Identification of a chemokine receptor encoded by human cytomegalovirus as a cofactor for HIV-1 entry. , 1997, Science.
[256] J. Corbeil,et al. Cutting edge: a novel viral TNF receptor superfamily member in virulent strains of human cytomegalovirus. , 1999, Journal of immunology.
[257] M. Greenberg,et al. Two elements target SIV Nef to the AP‐2 clathrin adaptor complex, but only one is required for the induction of CD4 endocytosis , 1999, The EMBO journal.
[258] R. Connor,et al. Change in Coreceptor Use Correlates with Disease Progression in HIV-1–Infected Individuals , 1997, The Journal of experimental medicine.
[259] E. Geras-Raaka,et al. Human Interferon-γ–inducible Protein 10 (IP-10) Inhibits Constitutive Signaling of Kaposi's Sarcoma–associated Herpesvirus G Protein–coupled Receptor , 1998, The Journal of experimental medicine.
[260] M. Spriggs,et al. One step ahead of the game: viral immunomodulatory molecules. , 1996, Annual review of immunology.
[261] S. Shchelkunov,et al. The cowpox virus-encoded homolog of the vaccinia virus complement control protein is an inflammation modulatory protein. , 1997, Virology.
[262] N. Horikoshi,et al. Oncogenic potential of the adenovirus E4orf6 protein. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[263] G. McFadden,et al. Myxoma virus M-T7, a secreted homolog of the interferon-gamma receptor, is a critical virulence factor for the development of myxomatosis in European rabbits. , 1996, Virology.
[264] T. Shenk,et al. Human Cytomegalovirus Inhibits Transcription of the CC Chemokine MCP-1 Gene , 1999, Journal of Virology.
[265] J. Schmitz,et al. Antibody-dependent complement-mediated cytotoxicity in sera from patients with HIV-1 infection is controlled by CD55 and CD59. , 1995, The Journal of clinical investigation.
[266] J L Sullivan,et al. Severe herpesvirus infections in an adolescent without natural killer cells. , 1989, The New England journal of medicine.
[267] N. Davis-Poynter,et al. From sabotage to camouflage: viral evasion of cytotoxic T lymphocyte and natural killer cell-mediated immunity. , 1998, Seminars in cell & developmental biology.
[268] P. Murphy,et al. Molecular piracy of mammalian interleukin-8 receptor type B by herpesvirus saimiri. , 1993, The Journal of biological chemistry.
[269] H. Kung,et al. Transforming Potential of the Herpesvirus Oncoprotein MEQ: Morphological Transformation, Serum-Independent Growth, and Inhibition of Apoptosis , 1998, Journal of Virology.
[270] M. Pandori,et al. Interaction of HIV-1 Nef with the cellular dileucine-based sorting pathway is required for CD4 down-regulation and optimal viral infectivity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[271] L. Björck,et al. The Fc binding site for streptococcal protein G is in the C gamma 2-C gamma 3 interface region of IgG and is related to the sites that bind staphylococcal protein A and human rheumatoid factors. , 1989, Journal of immunology.
[272] D. Trono,et al. Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner , 1999, Current Biology.
[273] J. Yates,et al. BHRF1 of Epstein-Barr virus, which is homologous to human proto-oncogene bcl2, is not essential for transformation of B cells or for virus replication in vitro , 1992, Journal of virology.
[274] O. Mandelboim,et al. The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells , 1997, Nature.
[275] J. Panus,et al. A third distinct tumor necrosis factor receptor of orthopoxviruses. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[276] J. Altman,et al. Mouse CD94/NKG2A Is a Natural Killer Cell Receptor for the Nonclassical Major Histocompatibility Complex (MHC) Class I Molecule Qa-1b , 1998, The Journal of experimental medicine.
[277] Progressive and persistent downregulation of surface CXCR4 in CD4(+) T cells infected with human herpesvirus 7. , 1998 .
[278] M. Hannink,et al. Adenovirus E3-10.4K/14.5K protein complex inhibits tumor necrosis factor-induced translocation of cytosolic phospholipase A2 to membranes , 1997, Journal of virology.
[279] G. Otting,et al. Random coil conformation of a Gly/Ala‐rich insert in IκBα excludes structural stabilization as the mechanism for protection against proteasomal degradation , 1998 .
[280] R. Black,et al. Viral inhibition of inflammation: Cowpox virus encodes an inhibitor of the interleukin-1β converting enzyme , 1992, Cell.
[281] L. Miller. Baculovirus interaction with host apoptotic pathways , 1997, Journal of cellular physiology.
[282] S. Beck,et al. A complex between the MHC class I homologue encoded by human cytomegalovirus and β2 microglobulin , 1990, Nature.
[283] J. Tschopp,et al. Inhibition of fas death signals by FLIPs. , 1998, Current opinion in immunology.
[284] David C. Johnson,et al. Direct contact with herpes simplex virus-infected cells results in inhibition of lymphokine-activated killer cells because of cell-to-cell spread of virus. , 1993, The Journal of infectious diseases.
[285] R L Ashley,et al. The acquisition of herpes simplex virus during pregnancy. , 1997, The New England journal of medicine.
[286] T. Schwartz,et al. A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus. , 1997, Science.
[287] E. E. Avila,et al. Antibody-induced caps in Entamoeba histolytica: isolation and electrophoretic analysis. , 1986, The Journal of infectious diseases.
[288] B. Moss,et al. Inhibition of the complement cascade by the major secretory protein of vaccinia virus. , 1990, Science.
[289] M. Lenburg,et al. Nef induces CD4 endocytosis: Requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain , 1994, Cell.
[290] J. Deisenhofer. Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution. , 1981, Biochemistry.
[291] P. Lachmann,et al. Complement and immunity to viruses , 1997, Immunological reviews.
[292] J. Schifferli,et al. Proteolytic cleavage of CR1 on human erythrocytes in vivo: evidence for enhanced cleavage in AIDS , 1994, European journal of immunology.
[293] V. Dixit,et al. A Novel Family of Viral Death Effector Domain-containing Molecules That Inhibit Both CD-95- and Tumor Necrosis Factor Receptor-1-induced Apoptosis* , 1997, The Journal of Biological Chemistry.
[294] U. Koszinowski,et al. A cytomegalovirus glycoprotein re‐routes MHC class I complexes to lysosomes for degradation , 1999, The EMBO journal.
[295] P. Branton,et al. Regulation of apoptosis by viral gene products , 1997, Journal of virology.
[296] G. Trinchieri,et al. Mechanism of Suppression of Cell-Mediated Immunity by Measles Virus , 1996, Science.
[297] A. Alcamí,et al. Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species soecificity , 1995, Cell.
[298] A. Alcamí,et al. Vaccinia, cowpox, and camelpox viruses encode soluble gamma interferon receptors with novel broad species specificity , 1995, Journal of virology.
[299] J. Pieters. MHC class II restricted antigen presentation. , 1997, Current opinion in immunology.
[300] P. A. Peterson,et al. A viral inhibitor of peptide transporters for antigen presentation , 1995, Nature.
[301] H. W. Chang,et al. The E3L and K3L vaccinia virus gene products stimulate translation through inhibition of the double-stranded RNA-dependent protein kinase by different mechanisms , 1993, Journal of virology.
[302] R. Dubose,et al. A poxvirus-encoded semaphorin induces cytokine production from monocytes and binds to a novel cellular semaphorin receptor, VESPR. , 1998, Immunity.
[303] W. Greene,et al. A dileucine motif in HIV-1 Nef acts as an internalization signal for CD4 downregulation and binds the AP-1 clathrin adaptor , 1998, Current Biology.
[304] P. A. Peterson,et al. Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[305] M. Greenberg,et al. The SH3 domain‐binding surface and an acidic motif in HIV‐1 Nef regulate trafficking of class I MHC complexes , 1998, The EMBO journal.
[306] A. Mercer,et al. A homolog of interleukin-10 is encoded by the poxvirus orf virus , 1997, Journal of virology.
[307] S. Shchelkunov,et al. Molecular mimicry of the inflammation modulatory proteins (IMPs) of poxviruses: evasion of the inflammatory response to preserve viral habitat , 1998, Journal of leukocyte biology.
[308] C. Mackay,et al. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. , 1997, Science.
[309] U. Koszinowski,et al. Identification and expression of a murine cytomegalovirus early gene coding for an Fc receptor , 1994, Journal of virology.
[310] G. Hayward,et al. Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6 , 1997, Nature Medicine.
[311] M. Mathews,et al. Interactions between the double-stranded RNA binding motif and RNA: definition of the binding site for the interferon-induced protein kinase DAI (PKR) on adenovirus VA RNA. , 1995, RNA.
[312] A. Abbas,et al. Functional roles of Fas and Bcl-2-regulated apoptosis of T lymphocytes. , 1998, Journal of immunology.
[313] S. Akira,et al. Defective NK cell activity and Th1 response in IL-18-deficient mice. , 1998, Immunity.
[314] B. Moss,et al. Characterization of a vaccinia virus-encoded 42-kilodalton class I membrane glycoprotein component of the extracellular virus envelope , 1992, Journal of virology.
[315] B. Barrell,et al. Analysis of the complete DNA sequence of murine cytomegalovirus , 1996, Journal of virology.
[316] D. Chao,et al. BCL-2 family: regulators of cell death. , 1998, Annual review of immunology.
[317] M. Greenberg,et al. Co‐localization of HIV‐1 Nef with the AP‐2 adaptor protein complex correlates with Nef‐induced CD4 down‐regulation , 1997, The EMBO journal.
[318] M. A. Saper,et al. Structure of the human class I histocompatibility antigen, HLA-A2 , 1987, Nature.
[319] C. Hutchison,et al. The DNA sequence of the human cytomegalovirus genome. , 1991, DNA sequence : the journal of DNA sequencing and mapping.
[320] A. Milon,et al. Characterization of a myxoma virus-encoded serpin-like protein with activity against interleukin-1 beta-converting enzyme , 1996, Journal of virology.
[321] J. Boss. Regulation of transcription of MHC class II genes. , 1997, Current opinion in immunology.
[322] M. Mathews,et al. Structure, function, and evolution of adenovirus-associated RNA: a phylogenetic approach , 1996, Journal of virology.
[323] A. Landay,et al. Decreased levels of complement receptor 1 (CD35) on B lymphocytes in persons with HIV infection. , 1995, Clinical immunology and immunopathology.
[324] L. Arthur,et al. HIV-1 and its envelope glycoprotein down-regulate chemotactic ligand receptors and chemotactic function of peripheral blood monocytes. , 1989, Journal of immunology.
[325] Robin A. Weiss,et al. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain , 1986, Cell.
[326] P. Åman,et al. The EBNA2-related resistance towards alpha interferon (IFN-alpha) in Burkitt's lymphoma cells effects induction of IFN-induced genes but not the activation of transcription factor ISGF-3 , 1992, Molecular and cellular biology.
[327] G. McFadden,et al. Myxoma virus induces extensive CD4 downregulation and dissociation of p56lck in infected rabbit CD4+ T lymphocytes , 1995, Journal of virology.
[328] M. Dierich,et al. Interaction of several complement proteins with gp120 and gp41, the two envelope gycoproteins of HIV‐1 , 1995, AIDS.
[329] K. Matsumoto,et al. Murine Nkg2d and Cd94 are clustered within the natural killer complex and are expressed independently in natural killer cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[330] P. Bjorkman,et al. Characterization of a Murine Cytomegalovirus Class I Major Histocompatibility Complex (MHC) Homolog: Comparison to MHC Molecules and to the Human Cytomegalovirus MHC Homolog , 1998, Journal of Virology.
[331] K. Ozato,et al. Kaposi’s Sarcoma-Associated Herpesvirus Viral Interferon Regulatory Factor , 1998, Journal of Virology.
[332] J. Said,et al. Kaposi's sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients. , 1997, Science.
[333] M. Foti,et al. The HIV-1 Nef protein acts as a connector with sorting pathways in the Golgi and at the plasma membrane. , 1997, Immunity.
[334] P. Farrell. Signal transduction from the Epstein-Barr virus LMP-1 transforming protein. , 1998, Trends in microbiology.
[335] E. Cesarman,et al. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator , 1998, Nature.
[336] D. Andrews,et al. A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes , 1994, Cell.
[337] M. Hurme,et al. Polymorphism of the interleukin-10 gene is associated with susceptibility to Epstein-Barr virus infection. , 1999, The Journal of infectious diseases.
[338] P. Allavena,et al. The viral chemokine macrophage inflammatory protein-II is a selective Th2 chemoattractant. , 1998, Blood.
[339] B. Hogue,et al. Molecular mimicry between Fc receptor and S peplomer protein of mouse hepatitis virus, bovine corona virus, and transmissible gastroenteritis virus. , 1995, Hybridoma.
[340] T. Watts,et al. Molecular chaperones in antigen presentation. , 1995, Current opinion in immunology.
[341] E. Geras-Raaka,et al. Kaposi's sarcoma-associated herpesvirus (KSHV) chemokine vMIP-II and human SDF-1alpha inhibit signaling by KSHV G protein-coupled receptor. , 1998, Biochemical and biophysical research communications.
[342] C. Karp. Measles: immunosuppression, interleukin‐12. and complement receptors , 1999, Immunological reviews.
[343] Guy S. Salvesen,et al. X-linked IAP is a direct inhibitor of cell-death proteases , 1997, Nature.
[344] E. Koonin,et al. Genome Sequence of a Human Tumorigenic Poxvirus: Prediction of Specific Host Response-Evasion Genes , 1996, Science.
[345] Y. Lazebnik,et al. Caspases: enemies within. , 1998, Science.
[346] L. Gooding,et al. Immune evasion by adenoviruses , 1999, Immunological reviews.
[347] T. Schall,et al. Cytomegalovirus-encoded beta chemokine promotes monocyte-associated viremia in the host. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[348] F. Maldarelli,et al. Human immunodeficiency virus type 1 Vpu protein is an oligomeric type I integral membrane protein , 1993, Journal of virology.
[349] H. Ploegh,et al. Trophoblast Class I Major Histocompatibility Complex (MHC) Products Are Resistant to Rapid Degradation Imposed by the Human Cytomegalovirus (HCMV) Gene Products US2 and US11 , 1998, The Journal of experimental medicine.
[350] W. Rozenbaum,et al. Decreased expression of the C3b/C4b complement receptor (CR1) in AIDS and AIDS-related syndromes correlates with clinical subpopulations of patients with HIV infection. , 1987, AIDS.
[351] H. Ploegh,et al. A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface , 1997, The EMBO journal.
[352] A. Strasser,et al. Bcl-2, Bcl-xL and adenovirus protein E1B19kD are functionally equivalent in their ability to inhibit cell death , 1997, Oncogene.
[353] K. Rosenthal,et al. Inhibition of human CTL-mediated lysis by fibroblasts infected with herpes simplex virus. , 1993, Journal of immunology.
[354] K. Yamanishi,et al. Human Herpesvirus 6 Open Reading Frame U83 Encodes a Functional Chemokine , 1999, Journal of Virology.
[355] D. Fearon. The complement system and adaptive immunity. , 1998, Seminars in immunology.
[356] M. Rocchi,et al. The chemokine receptor CCR8 is preferentially expressed in Th2 but not Th1 cells. , 1998, Journal of immunology.
[357] U. Schubert,et al. Differential activities of the human immunodeficiency virus type 1-encoded Vpu protein are regulated by phosphorylation and occur in different cellular compartments , 1994, Journal of virology.
[358] E. Cesarman,et al. Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation , 1997, Nature.
[359] S. Zolla-Pazner,et al. Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1 , 1995, The Journal of experimental medicine.
[360] R. Welsh,et al. Natural killer (NK) cell response to virus infections in mice with severe combined immunodeficiency. The stimulation of NK cells and the NK cell-dependent control of virus infections occur independently of T and B cell function , 1991, The Journal of experimental medicine.
[361] R. Redfield,et al. Human immunodeficiency virus type 1 has an additional coding sequence in the central region of the genome. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[362] P. van Oostveldt,et al. Antibody-induced endocytosis of viral glycoproteins and major histocompatibility complex class I on pseudorabies virus-infected monocytes. , 1999, The Journal of general virology.
[363] S. Beck,et al. Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens , 1988, Nature.
[364] J. Tschopp,et al. The fight of viruses against apoptosis. , 1998, Current opinion in genetics & development.
[365] Anthony S. Fauci,et al. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease , 1993, Nature.
[366] M. Mann,et al. ER‐60, a chaperone with thiol‐dependent reductase activity involved in MHC class I assembly , 1998, The EMBO journal.
[367] H. Ploegh,et al. Inhibition of Major Histocompatibility Complex Class I Antigen Presentation in Pig and Primate Cells by Herpes Simplex Virus Type 1 and 2 ICP47 , 1998, Journal of Virology.
[368] D. R. Taylor,et al. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. , 1999, Science.
[369] J. Bruder,et al. Interaction of the Adenovirus 14.7-kDa Protein with FLICE Inhibits Fas Ligand-induced Apoptosis* , 1998, The Journal of Biological Chemistry.
[370] V. Fischetti,et al. Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[371] H. Burgert,et al. The E3/19K protein of adenovirus type 2 binds to the domains of histocompatibility antigens required for CTL recognition. , 1987, The EMBO journal.
[372] C. Rivas,et al. African Swine Fever Virus GeneA179L,a Viral Homologue ofbcl-2, Protects Cells from Programmed Cell Death , 1996 .
[373] H. W. Chang,et al. The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[374] G. Carpenter,et al. Analysis of the influences of the E5 transforming protein on kinetic parameters of epidermal growth factor binding and metabolism , 1992, Journal of cellular physiology.
[375] Robert B Sim,et al. Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[376] F. Almazán,et al. The African swine fever virus IAP homolog is a late structural polypeptide. , 1995, Virology.
[377] T. Schall,et al. HHV8-encoded vMIP-I Selectively Engages Chemokine Receptor CCR8 , 1999, The Journal of Biological Chemistry.
[378] K. Früh,et al. Herpes Simplex Virus Type 2 ICP47 Inhibits Human TAP but Not Mouse TAP , 1998, Journal of Virology.
[379] T. Rapoport,et al. Sec6l-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction , 1996, Nature.
[380] A. Townsend,et al. Antigen recognition by class I-restricted T lymphocytes. , 1989, Annual review of immunology.
[381] A. Alcamí,et al. Vaccinia virus strains Lister, USSR and Evans express soluble and cell-surface tumour necrosis factor receptors. , 1999, The Journal of general virology.
[382] J. Verhoef,et al. Direct evidence for antibody bipolar bridging on herpes simplex virus-infected cells. , 1992, Immunology.
[383] C. Vita,et al. Chemokine Sequestration by Viral Chemoreceptors as a Novel Viral Escape Strategy: Withdrawal of Chemokines from the Environment of Cytomegalovirus-infected Cells , 1998, The Journal of experimental medicine.
[384] B. Pedersen,et al. Clinical Progression of HIV Infection: Role of NK Cells , 1997, Scandinavian journal of immunology.
[385] N. Stow,et al. Herpes simplex virus immunoglobulin G Fc receptor activity depends on a complex of two viral glycoproteins, gE and gI , 1988, Journal of virology.
[386] Luc Montagnier,et al. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV , 1984, Nature.
[387] F. Brodsky,et al. Interactions between HIV1 Nef and vacuolar ATPase facilitate the internalization of CD4. , 1998, Immunity.
[388] John D Lambris,et al. Immune evasion properties of herpes simplex virus type 1 glycoprotein gC , 1996, Journal of virology.
[389] M. Androlewicz,et al. Herpes Simplex Virus Inhibitor ICP47 Destabilizes the Transporter Associated with Antigen Processing (TAP) Heterodimer* , 1998, The Journal of Biological Chemistry.
[390] S. Burrows,et al. Isolation of cytotoxic T lymphocytes from healthy seropositive individuals specific for peptide epitopes from Epstein-Barr virus nuclear antigen 1: implications for viral persistence and tumor surveillance. , 1995, Virology.
[391] J. Bertin,et al. Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[392] J. Marsh,et al. The numerous effector functions of Nef. , 1999, Archives of biochemistry and biophysics.
[393] S. Cory,et al. The Bcl-2 protein family: arbiters of cell survival. , 1998, Science.
[394] B. Cullen,et al. Inhibition of HIV-1 progeny virion release by cell-surface CD4 is relieved by expression of the viral Nef protein , 1999, Current Biology.
[395] P. Spear,et al. Membrane proteins specified by herpes simplex viruses. V. Identification of an Fc-binding glycoprotein , 1979, Journal of virology.
[396] B. Moss,et al. Broad spectrum chemokine antagonistic activity of a human poxvirus chemokine homolog. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[397] D. Sedmak,et al. Human Cytomegalovirus Inhibits Major Histocompatibility Complex Class II Expression By Disruption of the Jak/Stat Pathway , 1998, The Journal of experimental medicine.
[398] P. Doherty,et al. Forced degradation of Fas inhibits apoptosis in adenovirus-infected cells , 1998, Nature.
[399] P. Allavena,et al. Differential Expression of Chemokine Receptors and Chemotactic Responsiveness of Type 1 T Helper Cells (Th1s) and Th2s , 1998, The Journal of experimental medicine.
[400] John D Lambris,et al. Interaction of vaccinia virus complement control protein with human complement proteins: factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway. , 1998, Journal of immunology.
[401] H. Ploegh,et al. The cytosolic tail of class I MHC heavy chain is required for its dislocation by the human cytomegalovirus US2 and US11 gene products. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[402] J. Sodroski,et al. Identification of a protein encoded by the vpu gene of HIV-1 , 1988, Nature.
[403] U. Koszinowski,et al. A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter. , 1997, Immunity.